Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Oct 01, 2024

SELL
$95.27 - $108.47 $387,653 - $441,364
-4,069 Closed
0 $0
Q4 2023

Oct 01, 2024

BUY
$92.27 - $101.54 $375,446 - $413,166
4,069 New
4,069 $310 Million
Q3 2021

Oct 02, 2024

SELL
$81.78 - $95.14 $155,545 - $180,956
-1,902 Closed
0 $0
Q2 2021

Oct 02, 2024

BUY
$85.24 - $94.15 $162,126 - $179,073
1,902 New
1,902 $529 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Cannon Financial Strategists, Inc. Portfolio

Follow Cannon Financial Strategists, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cannon Financial Strategists, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cannon Financial Strategists, Inc. with notifications on news.